Popular Diabetes Drug Class Lowered Risk of 10 Obesity-Associated Cancers
Med Page Today
JULY 5, 2024
(MedPage Today) -- GLP-1 receptor agonists lowered the risk of several obesity-associated cancers, a retrospective analysis of electronic health records suggested. Compared with insulin, GLP-1s were associated with a lower risk for developing.
Let's personalize your content